Observational Study Using Residual Patient Samples for Research
This is an observational study that uses leftover (residual) de-identified patient samples, such as blood, bone marrow, DNA, or tissue, that were originally sent to LabPMM for clinical testing. Researchers are looking to collect these samples from patients aged 18 and older who have hematologic diseases (blood disorders). The goal is to gather up to 2000 samples over three years for clinical research at LabPMM or partner institutions. This study aims to understand more about diseases by studying these samples, specifically looking at mechanisms related to RAF. There are no specific interventions or drugs being tested in this study; it focuses on collecting and analyzing existing samples.
- Study design
- This is an observational study with a planned enrollment of 2000 participants. It is not specified if it is randomized or blinded.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoint is enrollment, measured at 3 years. It is not specified if participants are followed after this.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research
At a glance
Conditions
NCT06222164
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
LabPMM
San Diego, Californiastudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Enrollment3 years
N=2000